The Rheumatology Podcast

Prof Jaap van Laar talks to Dr Ed Roddy, Keele University, UK, about the recently published update of the BSR guideline for the management of gout. Dr Roddy explains the need for this update due to the development of new drugs to treat gout as well as epidemiological studies showing an increase of incidence and prevalence but a lack of improvement in the treatment of gout. The guideline highlights the importance of increasing both GP and patient education. It also suggests a paradigm shift in the treatment to using urate lowering drugs in all patients and not waiting until a chronic condition develops.

Prof van Laar and Dr James Galloway, King’s College London, UK, talk about the BSR guideline for the prescription and monitoring of non-biologic DMARDs. Dr Galloway explains the need for this update of existing guidelines due development of new drugs and previous treatments no longer being used. He highlights the headline changes from the previous guideline and discusses one of the more controversial recommendations made.

Prof Jaap van Laar, Editor of Rheumatology, and Associate Editors Dr James Galloway (King’s College London) and Dr Marwan Bukhari (University Hospitals of Morecambe Bay Foundation NHS trust) discuss the impact of social media on science. The rise of social media as a method of news consumption has created a society that wants convenient, succinct information. Subtle changes in the way information is conveyed are amplified the further down the chain you get, as evidenced recently when a paper’s meaning became lost within social media. The rise of alternative metrics to measure impact has also led to success and infamy being measured in equal manner.

Prof Jaap van Laar talks to Dr Elizabeth Price, Great Western Hospital NHS Foundation Trust, UK, about the BSR guidelines the management of Sjögren’s syndrome. Dr Price explains the development of the guidelines with specials across rheumatology, oral medicine and ophthalmology as well as occupational therapists and patient representatives to produce a particle guide for the management of Sjörgren’s that can be used across disciplines. The aim of the guideline is to allow early detection and treatment using a holistic and personalised approach to improve the patient’s current condition and long term prognosis.

Prof van Laar and Dr James Galloway, King’s College London, UK, talk about the BSR guideline for the prescription and monitoring of non-biologic DMARDs. Dr Galloway explains the need for this update of existing guidelines due development of new drugs and previous treatments no longer being used. He highlights the headline changes from the previous guideline and discusses one of the more controversial recommendations made.

Prof Jaap van Laar, Editor of Rheumatology, and Associate Editors Dr James Galloway (King’s College London) and Dr Marwan Bukhari (University Hospitals of Morecambe Bay Foundation NHS trust) discuss the impact of social media on science. The rise of social media as a method of news consumption has created a society that wants convenient, succinct information. Subtle changes in the way information is conveyed are amplified the further down the chain you get, as evidenced recently when a paper’s meaning became lost within social media. The rise of alternative metrics to measure impact has also led to success and infamy being measured in equal manner.

Prof Jaap van Laar talks to Dr Elizabeth Price, Great Western Hospital NHS Foundation Trust, UK, about the BSR guidelines the management of Sjögren’s syndrome. Dr Price explains the development of the guidelines with specials across rheumatology, oral medicine and ophthalmology as well as occupational therapists and patient representatives to produce a particle guide for the management of Sjörgren’s that can be used across disciplines. The aim of the guideline is to allow early detection and treatment using a holistic and personalised approach to improve the patient’s current condition and long term prognosis.

Prof Jaap van Laar talks to Dr Elizabeth Price, Great Western Hospital NHS Foundation Trust, UK, about the BSR guidelines the management of Sjögren’s syndrome. Dr Price explains the development of the guidelines with specials across rheumatology, oral medicine and ophthalmology as well as occupational therapists and patient representatives to produce a particle guide for the management of Sjörgren’s that can be used across disciplines. The aim of the guideline is to allow early detection and treatment using a holistic and personalised approach to improve the patient’s current condition and long term prognosis.

Prof van Laar and Dr James Galloway, King’s College London, UK, talk about the BSR guideline for the prescription and monitoring of non-biologic DMARDs. Dr Galloway explains the need for this update of existing guidelines due development of new drugs and previous treatments no longer being used. He highlights the headline changes from the previous guideline and discusses one of the more controversial recommendations made.

Prof Jaap van Laar, Editor of Rheumatology, and Associate Editors Dr James Galloway (King’s College London) and Dr Marwan Bukhari (University Hospitals of Morecambe Bay Foundation NHS trust) discuss the impact of social media on science. The rise of social media as a method of news consumption has created a society that wants convenient, succinct information. Subtle changes in the way information is conveyed are amplified the further down the chain you get, as evidenced recently when a paper’s meaning became lost within social media. The rise of alternative metrics to measure impact has also led to success and infamy being measured in equal manner.